Collectively, our studies show that CD44 and CCR2 contribute to hepatitis in a model of NAFLD despite histological evidence of steatosis and elevated serological markers of hepatocellular damage. The gene discussed is CD44; the disease is metabolic dysfunction-associated steatotic liver disease.